1887

Abstract

(RVFV) is the most pathogenic member of the genus within the family , and can cause severe disease in humans and livestock. Until recently, limited information has been published on the cellular host response elicited by RVFV, particularly in macrophages and dendritic cells, which play critical roles in stimulating adaptive and innate immune responses to viral infection. In an effort to define the initial response of host immunomodulatory cells to infection, primary mouse bone marrow derived macrophages (BMDM) were infected with the pathogenic RVFV strain ZH501, or attenuated strains MP-12 or MP-12 based Clone13 type (rMP12-C13 type), and cytokine secretion profiles examined. The secretion of T helper (Th)1-associated antiviral cytokines, chemokines and various interleukins increased rapidly after infection with the attenuated rMP12-C13 type RVFV, which lacks a functional NSs virulence gene. In comparison, infection with live-attenuated MP-12 encoding a functional NSs gene appeared to cause a delayed immune response, while pathogenic ZH501 ablates the immune response almost entirely. These data demonstrate that NSs can inhibit components of the BMDM antiviral response and supports previous work indicating that NSs can specifically regulate the type I interferon response in macrophages. Furthermore, our data demonstrate that genetic differences between ZH501 and MP-12 reduce the ability of MP-12 to inhibit antiviral signalling and subsequently reduce virulence in BMDM, demonstrating that viral components other than NSs play a critical role in regulating the host response to RVFV infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.000119
2015-07-01
2021-07-30
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/7/1651.html?itemId=/content/journal/jgv/10.1099/vir.0.000119&mimeType=html&fmt=ahah

References

  1. Abdel-Wahab K.S., El Baz L.M., El-Tayeb E.M., Omar H., Ossman M.A., Yasin W. (1978). Rift Valley fever virus infections in Egypt: pathological and virological findings in manTrans R Soc Trop Med Hyg 72392396 [View Article][PubMed]. [Google Scholar]
  2. Al Azraqi T.A., El Mekki A.A., Mahfouz A.A. (2013). Rift Valley fever among children and adolescents in southwestern Saudi ArabiaJ Infect Public Health 6230235 [View Article][PubMed]. [Google Scholar]
  3. Alazawi W., Heath H., Waters J.A., Woodfin A., O'Brien A.J., Scarzello A.J., Ma B., Lopez-Otalora Y., Jacobs M., other authors. (2013). STAT2 loss leads to cytokine-independent, cell-mediated lethality in LPS-induced sepsisProc Natl Acad Sci USA 11086568661 [View Article][PubMed]. [Google Scholar]
  4. Askari N., Beenstock J., Livnah O., Engelberg D. (2009). p38alpha is active in vitro and in vivo when monophosphorylated at threonine 180Biochemistry 4824972504 [View Article][PubMed]. [Google Scholar]
  5. Austin D., Baer A., Lundberg L., Shafagati N., Schoonmaker A., Narayanan A., Popova T., Panthier J.J., Kashanchi F., other authors. (2012). p53 Activation following Rift Valley fever virus infection contributes to cell death and viral productionPLoS ONE 7e36327 [View Article][PubMed]. [Google Scholar]
  6. Billecocq A., Spiegel M., Vialat P., Kohl A., Weber F., Bouloy M., Haller O. (2004). NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcriptionJ Virol 7897989806 [View Article][PubMed]. [Google Scholar]
  7. Bird B.H., Ksiazek T.G., Nichol S.T., Maclachlan N.J. (2009). Rift Valley fever virusJ Am Vet Med Assoc 234883893 [View Article][PubMed]. [Google Scholar]
  8. Bol S.M., Booiman T., Bunnik E.M., Moerland P.D., van Dort K., Strauss J.F. III, Sieberer M., Schuitemaker H., Kootstra N.A., van't Wout A.B. (2011a). Polymorphism in HIV-1 dependency factor PDE8A affects mRNA level and HIV-1 replication in primary macrophagesVirology 4203242 [View Article][PubMed]. [Google Scholar]
  9. Bol S.M., Cobos-Jimenez V., Kootstra N.A., van't Wout A.B. (2011b). HIV-1 and the macrophageFuture Virology 6187208 [View Article]. [Google Scholar]
  10. Bouloy M., Janzen C., Vialat P., Khun H., Pavlovic J., Huerre M., Haller O. (2001). Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSsJ Virol 7513711377 [View Article][PubMed]. [Google Scholar]
  11. Bray M., Geisbert T.W. (2005). Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic feverInt J Biochem Cell Biol 3715601566 [View Article][PubMed]. [Google Scholar]
  12. Cargnello M., Roux P.P. (2011). Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinasesMicrobiol Mol Biol Rev 755083 [View Article][PubMed]. [Google Scholar]
  13. Chia J.K., Pollack M., Guelde G., Koles N.L., Miller M., Evans M.E. (1989). Lipopolysaccharide (LPS)-reactive monoclonal antibodies fail to inhibit LPS-induced tumor necrosis factor secretion by mouse-derived macrophagesJ Infect Dis 159872880 [View Article][PubMed]. [Google Scholar]
  14. Chowdhury F.Z., Farrar J.D. (2013). STAT2: a shape-shifting anti-viral super STATJAK-STAT 2e23633 [View Article][PubMed]. [Google Scholar]
  15. Cuadrado A., Nebreda A.R. (2010). Mechanisms and functions of p38 MAPK signallingBiochem J 429403417 [View Article][PubMed]. [Google Scholar]
  16. Davies F.G. (2010). The historical and recent impact of Rift Valley fever in AfricaAm J Trop Med Hyg 837374 [View Article][PubMed]. [Google Scholar]
  17. Davies F.G., Martin V. . (editors) (2003). Recognizing Rift Valley FeverRomeFood and Agriculture Organization of the United Nations. [Google Scholar]
  18. do Valle T.Z., Billecocq A., Guillemot L., Alberts R., Gommet C., Geffers R., Calabrese K., Schughart K., Bouloy M., other authors. (2010). A new mouse model reveals a critical role for host innate immunity in resistance to Rift Valley feverJ Immunol 18561466156 [View Article][PubMed]. [Google Scholar]
  19. Dupuis-Maguiraga L., Noret M., Brun S., Le Grand R., Gras G., Roques P. (2012). Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgiaPLoS Negl Trop Dis 6e1446 [View Article][PubMed]. [Google Scholar]
  20. Ermler M.E., Traylor Z., Patel K., Schattgen S.A., Vanaja S.K., Fitzgerald K.A., Hise A.G. (2014). Rift Valley fever virus infection induces activation of the NLRP3 inflammasomeVirology 449174180 [View Article][PubMed]. [Google Scholar]
  21. Findlay G.M., Daubney R. (1931). The virus of Rift Valley Fever or enzootic hepatitisLancet 22113501351 [View Article]. [Google Scholar]
  22. Gear J.H. (1977). Haemorrhagic fevers of Africa: an account of two recent outbreaksJ S Afr Vet Assoc 4858Medline. [Google Scholar]
  23. Gough D.J., Sabapathy K., Ko E.Y., Arthur H.A., Schreiber R.D., Trapani J.A., Clarke C.J., Johnstone R.W. (2007). A novel c-Jun-dependent signal transduction pathway necessary for the transcriptional activation of interferon gamma response genesJ Biol Chem 282938946 [View Article][PubMed]. [Google Scholar]
  24. Gray K.K., Worthy M.N., Juelich T.L., Agar S.L., Poussard A., Ragland D., Freiberg A.N., Holbrook M.R. (2012). Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mousePLoS Negl Trop Dis 6e1529.[CrossRef] [Google Scholar]
  25. Head J.A., Kalveram B., Ikegami T. (2012). Functional analysis of Rift Valley fever virus NSs encoding a partial truncationPLoS ONE 7e45730 [View Article][PubMed]. [Google Scholar]
  26. Ikegami T., Won S., Peters C.J., Makino S. (2006). Rescue of infectious Rift Valley Fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign geneJ Virol 8029332940 [View Article][PubMed]. [Google Scholar]
  27. Ikegami T., Narayanan K., Won S., Kamitani W., Peters C.J., Makino S. (2009a). Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKRAnn N Y Acad Sci 1171(Suppl 1), E75E85 [View Article][PubMed]. [Google Scholar]
  28. Ikegami T., Narayanan K., Won S., Kamitani W., Peters C.J., Makino S. (2009b). Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylationPLoS Pathog 5e1000287 [View Article][PubMed]. [Google Scholar]
  29. Jansen van Vuren P., Tiemessen C., Paweska J.T. (2011). Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in micePLoS ONE 6e25027 [View Article][PubMed]. [Google Scholar]
  30. Kalveram B., Lihoradova O., Indran S.V., Ikegami T. (2011). Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacyJ Vis Exp 57e3400Medline. [Google Scholar]
  31. Kalveram B., Lihoradova O., Indran S.V., Lokugamage N., Head J.A., Ikegami T. (2013). Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKRVirology 435415424 [View Article][PubMed]. [Google Scholar]
  32. Kamal S.A. (2009). Pathological studies on postvaccinal reactions of Rift Valley fever in goatsVirol J 694 [View Article][PubMed]. [Google Scholar]
  33. Kang Y.J., Seit-Nebi A., Davis R.J., Han J. (2006). Multiple activation mechanisms of p38alpha mitogen-activated protein kinaseJ Biol Chem 2812622526234 [View Article][PubMed]. [Google Scholar]
  34. Kasari T.R., Carr D.A., Lynn T.V., Weaver J.T. (2008). Evaluation of pathways for release of Rift Valley fever virus into domestic ruminant livestock, ruminant wildlife, and human populations in the continental United StatesJ Am Vet Med Assoc 232514529 [View Article][PubMed]. [Google Scholar]
  35. Kawai T., Akira S. (2007). Antiviral signaling through pattern recognition receptorsJ Biochem 141137145 [View Article][PubMed]. [Google Scholar]
  36. Le May N., Mansuroglu Z., Léger P., Josse T., Blot G., Billecocq A., Flick R., Jacob Y., Bonnefoy E., Bouloy M. (2008). A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cellsPLoS Pathog 4e13 [View Article][PubMed]. [Google Scholar]
  37. Lewis R.M., Cosgriff T.M., Peters C.J., Morrill J.C. (1987). Differentiation of a human monocytic cell line associated with increased production of Rift Valley fever virus by infected cellsJ Med Virol 23207215 [View Article][PubMed]. [Google Scholar]
  38. Lokugamage N., Freiberg A.N., Morrill J.C., Ikegami T. (2012). Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strainsJ Virol 861356613575 [View Article][PubMed]. [Google Scholar]
  39. Ma X., Sun J., Papasavvas E., Riemann H., Robertson S., Marshall J., Bailer R.T., Moore A., Donnelly R.P., other authors. (2000). Inhibition of IL-12 production in human monocyte-derived macrophages by TNFJ Immunol 16417221729 [View Article][PubMed]. [Google Scholar]
  40. Maar S.A., Swanepoel R., Gelfand M. (1979). Rift Valley fever encephalitis. A description of a caseCent Afr J Med 25811Medline. [Google Scholar]
  41. Mapaco L.P., Coetzer J.A., Paweska J.T., Venter E.H. (2012). An investigation into an outbreak of Rift Valley fever on a cattle farm in Bela-Bela, South Africa, in 2008J S Afr Vet Assoc 83132 [View Article][PubMed]. [Google Scholar]
  42. McElroy A.K., Nichol S.T. (2012). Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infectionVirology 422612 [View Article][PubMed]. [Google Scholar]
  43. Meek D.W. (2009). Tumour suppression by p53: a role for the DNA damage response?Nat Rev Cancer 9714723Medline. [Google Scholar]
  44. Menendez D., Shatz M., Azzam K., Garantziotis S., Fessler M.B., Resnick M.A. (2011). The Toll-like receptor gene family is integrated into human DNA damage and p53 networksPLoS Genet 7e1001360 [View Article][PubMed]. [Google Scholar]
  45. Mills C.D. (2012). M1 and M2 macrophages: oracles of health and diseaseCrit Rev Immunol 32463488 [View Article][PubMed]. [Google Scholar]
  46. Morrill J.C., Jennings G.B., Cosgriff T.M., Gibbs P.H., Peters C.J. (1989). Prevention of Rift Valley fever in rhesus monkeys with interferon-alphaRev Infect Dis 11(Suppl 4), S815S825 [View Article][PubMed]. [Google Scholar]
  47. Morrill J.C., Jennings G.B., Johnson A.J., Cosgriff T.M., Gibbs P.H., Peters C.J. (1990). Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon responseArch Virol 110195212 [View Article][PubMed]. [Google Scholar]
  48. Morrill J.C., Czarniecki C.W., Peters C.J. (1991). Recombinant human interferon-gamma modulates Rift Valley fever virus infection in the rhesus monkeyJ Interferon Res 11297304 [View Article][PubMed]. [Google Scholar]
  49. Narayanan A., Popova T., Turell M., Kidd J., Chertow J., Popov S.G., Bailey C., Kashanchi F., Kehn-Hall K. (2011). Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infectionPLoS ONE 6e20354 [View Article][PubMed]. [Google Scholar]
  50. Pan C.H., Kim E.S., Jung S.H., Nho C.W., Lee J.K. (2008). Tectorigenin inhibits IFN-gamma/LPS-induced inflammatory responses in murine macrophage RAW 264.7 cellsArch Pharm Res 3114471456 [View Article][PubMed]. [Google Scholar]
  51. Remy G., Risco A.M., Iñesta-Vaquera F.A., González-Terán B., Sabio G., Davis R.J., Cuenda A. (2010). Differential activation of p38MAPK isoforms by MKK6 and MKK3Cell Signal 22660667 [View Article][PubMed]. [Google Scholar]
  52. Schoenborn J.R., Wilson C.B. (2007). Regulation of interferon-gamma during innate and adaptive immune responsesAdv Immunol 9641101 [View Article][PubMed]. [Google Scholar]
  53. Schwentker F.F., Rivers T.M. (1934). Rift Valley fever in man: report of a fatal laboratory infection complicated by thrombophlebitisJ Exp Med 59305313 [View Article][PubMed]. [Google Scholar]
  54. Shieh W.J., Paddock C.D., Lederman E., Rao C.Y., Gould L.H., Mohamed M., Mosha F., Mghamba J., Bloland P., other authors. (2010). Pathologic studies on suspect animal and human cases of Rift Valley fever from an outbreak in Eastern Africa, 2006–2007Am J Trop Med Hyg 83(Suppl), 3842 [View Article][PubMed]. [Google Scholar]
  55. Smith D.R., Steele K.E., Shamblin J., Honko A., Johnson J., Reed C., Kennedy M., Chapman J.L., Hensley L.E. (2010). The pathogenesis of Rift Valley fever virus in the mouse modelVirology 407256267 [View Article][PubMed]. [Google Scholar]
  56. Swanepoel R., Coetzer J.A.W. (1994). Rift Valley fever. In Infectious Diseases of Livestock, Vol. I pp. 688717. Edited by Coetzer J. A. W., Thomson G. R., Tustin R. C. New YorkOxford University Press. [Google Scholar]
  57. Swanepoel R., Coetzer J.A.W. (2004). Rift Valley fever. In Infectious Diseases of Livestock, 2nd edn, pp. 10381070. Edited by Coetzer J. A. W., Tustin R. C. Cape TownOxford University Press. [Google Scholar]
  58. Tugal D., Liao X., Jain M.K. (2013). Transcriptional control of macrophage polarizationArterioscler Thromb Vasc Biol 3311351144 [View Article][PubMed]. [Google Scholar]
  59. Yi P.F., Bi W.Y., Shen H.Q., Wei Q., Zhang L.Y., Dong H.B., Bai H.L., Zhang C., Song Z., other authors. (2013). Inhibitory effects of sulfated 20(S)-ginsenoside Rh2 on the release of pro-inflammatory mediators in LPS-induced RAW 264.7 cellsEur J Pharmacol 7126066 [View Article][PubMed]. [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.000119
Loading
/content/journal/jgv/10.1099/vir.0.000119
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error